Needham Reiterates Hold on Moderna
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Joseph Stringer has reiterated a Hold rating on Moderna (NASDAQ:MRNA).
June 28, 2024 | 10:31 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Needham analyst Joseph Stringer has reiterated a Hold rating on Moderna. This suggests that the analyst does not see significant upside or downside potential in the short term.
The Hold rating indicates that the analyst believes Moderna's stock is fairly valued at its current price. This suggests limited short-term movement in the stock price, as the analyst does not foresee significant positive or negative catalysts.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100